Alpha Teknova (TKNO) Asset Writedowns and Impairment (2020 - 2026)
Alpha Teknova (TKNO) posted quarterly Asset Writedowns and Impairment of $7000.0 for Q1 2026, down 98.4% year-over-year from $437000.0 in Q1 2025, and down 98.47% quarter-over-quarter from $458000.0 in Q4 2025.
Alpha Teknova (TKNO) Asset Writedowns and Impairment (2020 - 2026) Analysis & Trends
Alpha Teknova (TKNO) has reported Asset Writedowns and Impairment for 7 consecutive years, with $7000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Asset Writedowns and Impairment fell 98.4% year-over-year to $7000.0; the TTM figure through Mar 2026 stood at $1.7 million (up 233.0% YoY), while the FY2025 annual figure was $2.1 million, up 1526.92% from the prior year.
- Asset Writedowns and Impairment fell to $7000.0 in Q1 2026 per TKNO's latest filing, from $458000.0 in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $2.2 million in Q2 2023 and bottomed at -$109000.0 in Q4 2023.
- Historically, Asset Writedowns and Impairment has averaged $412500.0 across 5 years, with a median of $253000.0 in 2024.
- Annual changes were most pronounced in 2023 — Asset Writedowns and Impairment plunged 116.44% — and 2025, when it surged 6142.86%.
- Alpha Teknova's Asset Writedowns and Impairment stood at $663000.0 in 2022, then slumped by 116.44% to -$109000.0 in 2023, then surged by 163.3% to $69000.0 in 2024, then soared by 563.77% to $458000.0 in 2025, then sank by 98.47% to $7000.0 in 2026.
- Business Quant data shows TKNO's Asset Writedowns and Impairment at $7000.0 in Q1 2026, $458000.0 in Q4 2025, and $732000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Alpha Teknova | 374.37 Mn | 356.94 Mn | 4.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 412,000.00 |
| Jun 30, 2026 | 412,000.00 |
| Mar 31, 2026 | 7,000.00 |
| Mar 31, 2026 | 7,000.00 |
| Dec 31, 2025 | 458,000.00 |
| Dec 31, 2025 | 458,000.00 |
| Sep 30, 2025 | 732,000.00 |
| Sep 30, 2025 | 732,000.00 |
| Jun 30, 2025 | 488,000.00 |
| Jun 30, 2025 | 488,000.00 |
| Mar 31, 2025 | 437,000.00 |
| Mar 31, 2025 | 437,000.00 |
| Dec 31, 2024 | 69,000.00 |
| Dec 31, 2024 | 69,000.00 |
| Mar 31, 2024 | 7,000.00 |
| Mar 31, 2024 | 7,000.00 |
| Dec 31, 2023 | -109,000.00 |
| Dec 31, 2023 | -109,000.00 |
| Jun 30, 2023 | 2.20 Mn |
| Jun 30, 2023 | 2.20 Mn |